ProgramSignal
Home
About
Programs
Endpoints
News
Community
Sign in
Sign up →
Search
Showing studies matching your search
1 results shown
Studies (1 shown)
NCT04821622
PHASE3
ACTIVE_NOT_RECRUITING
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Sponsor
· Pfizer
Condition
· Prostate Cancer
Intervention
· talazoparib plus enzalutamide, Placebo plus enzalutamide
Updated Apr 2026
Showing top 1 results.
See all 1 results on CT.gov →